Member Info for Aether

https://twitter.com/EricTopol/status/1522542891108904960

"We've known about the potential of interferon therapy to prevent severe Covid, but finally a randomized trial of 1900 mostly vaccinated people showed a 50% reduction in need for hospitalization ... "

Can someone ask whether he's going or not?

Deep dive data + Activ-2 data + new clinical trial = T/O.

Lima Liam - It is becoming obvious that it's a personality disorder or a serious mental illness.

How many of the sock puppets are his?

RobScott/Burstead/Nemo, etc is the guy running all the sockpuppets. It is has a personality disorder and serious mental health issues. Also, don't reveal any personal information online.

Green bin it.

Why are they still buying? They have already gone over 25%.

What is the pattern?

A lot of interest in Interferon from influential people. Let's hope the deep dive reveals statistical significance in some sub-groups.

If this is true, will it encourage either a Gov or Big pharma to put SNG on another trial?

Manifesto

Why bother replying to sockpuppets? It's what it wants. Stop feeding its insanity.

You can see from the writing style that it's just another sockpuppet.

Thank you, Palladin.

I don't think they're immature. I suspect they're ill.

Another sock puppet account.

RobScott/Nemo/Berkhead, etc is obviously mentally ill or has a serious personality disorder. It has been banned from numerous forums.

Don't reveal any personal information.

I had already have searched their address.

It leads to a bleak residential building in NJ.

The twitter account hasn't been updated since 2020.

Who hired them? Why did they make this?

Who commissioned this? Who are the company?

£3 without EUA is unlikely after The RNS and no new trial and no new data.

The market has lost confidence. A large pharma could probably buy this now for 50p to £1. That would value it at between £100,000,000 and £200,000,0000. Generous in the circumstances. *IF* we are put on a Trial, there is good data from DD S3, Activ-2 P2, and Long Covid data then the value would increase. To what level I don't know but at the moment it could be T/O for 50p.

Palladin

"I do not see a major recovery in the share price from the Sprinter deep-dive data alone?"

AGREE. The Sprinter results have shaken the confidence of the market. This is compounded by many negative articles on the results.

"An EUA application resulting in potential income generation would be a significant step forward."

DISAGREE. Not going to happen. Look at EIGER. They passed their endpoints. It is no longer easy to get an EUA.

"Similarly, progression to a major (Platform or reformatted Activ) trial would be indicative of future earning capacity."

AGREE. This might increase the share price.

"Either of these measures would surely take the share price back to pre Feb 21 levels or better?"

DISAGREE. It would take a lot more to take the sp to pre Feb 21 levels or better.

You'd need an EUA or a bidding war on T/O to take it to Feb 21 levels or better.

Manifesto

With 200m shares at £3 a share that's £600m. How did you get that figure!